| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REGN | Healthcare | Benchmark | Downgrade | Buy → Hold | — | $68.5B | $647.63 | -7.4% | -5.6% | +1.8% | -1.0% | +1.0% | +0.7% |
| QRVO | Technology | Argus | Downgrade | Buy → Hold | — | $9.0B | $154.46 | -0.3% | +1.0% | +2.1% | -1.0% | -2.1% | +2.2% |
| GIL | Consumer Cyclical | Stifel | Downgrade | Buy → Hold | — | $8.4B | $40.66 | +0.3% | -0.7% | +2.4% | +1.5% | +0.3% | +0.2% |
| IBP | Consumer Cyclical | RBC Capital | Downgrade | Outperform → Sector Perform | — | $5.5B | $130.07 | -0.3% | +2.0% | -0.7% | +0.1% | -0.5% | +0.1% |
| GRFS | Healthcare | Deutsche Bank | Downgrade | Buy → Hold | — | $5.3B | $12.49 | -0.7% | -2.2% | +2.3% | -1.6% | +0.0% | -2.0% |
| PTON | Consumer Cyclical | Exane BNP Paribas | Downgrade | Outperform → Neutral | — | $2.0B | $86.06 | -33.6% | -35.3% | -7.9% | -2.2% | -2.4% | +3.2% |
| PTON | Consumer Cyclical | MKM Partners | Downgrade | Buy → Neutral | — | $2.0B | $86.06 | -33.6% | -35.3% | -7.9% | -2.2% | -2.4% | +3.2% |
| PTON | Consumer Cyclical | Truist | Downgrade | Buy → Hold | — | $2.0B | $86.06 | -33.6% | -35.3% | -7.9% | -2.2% | -2.4% | +3.2% |
| PTON | Consumer Cyclical | Stifel | Downgrade | Buy → Hold | — | $2.0B | $86.06 | -33.6% | -35.3% | -7.9% | -2.2% | -2.4% | +3.2% |
| PTON | Consumer Cyclical | Telsey Advisory Group | Downgrade | Outperform → Market Perform | — | $2.0B | $86.06 | -33.6% | -35.3% | -7.9% | -2.2% | -2.4% | +3.2% |
| NOMD | Consumer Defensive | Goldman Sachs | Downgrade | Buy → Neutral | — | $1.5B | $27.48 | -3.0% | -7.2% | -2.6% | +2.9% | +0.9% | -0.7% |
| PZZA | Consumer Cyclical | Deutsche Bank | Downgrade | Buy → Hold | — | $1.1B | $140.01 | -2.9% | -5.5% | -1.6% | +1.4% | -2.6% | +1.1% |
| PZZA | Consumer Cyclical | Northcoast Research | Downgrade | Buy → Neutral | — | $1.1B | $140.01 | -2.9% | -5.5% | -1.6% | +1.4% | -2.6% | +1.1% |
| CYRX | Industrials | Roth Capital | Downgrade | Buy → Neutral | — | $652M | $83.29 | -7.2% | -2.4% | +2.4% | -2.5% | -5.0% | -2.3% |
| BGS | Consumer Defensive | Piper Sandler | Downgrade | Neutral → Underweight | — | $326M | $32.51 | -6.0% | +2.2% | +1.6% | -2.0% | -1.2% | +0.1% |